Download PDF
Semin Musculoskelet Radiol 2002; 06(4): 323-330
DOI: 10.1055/s-2002-36731
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Nuclear Medicine Studies in Metabolic Bone Disease

Sharon F. Hain, Ignac Fogelman
  • Department of Nuclear Medicine, Guy's and St Thomas' NHS Trust and Department of Radiological Sciences, Guy's, King's, and St Thomas' School of Medicine, King's College, London, England
Further Information

Publication History

Publication Date:
22 January 2003 (online)

Also available at
    Permissions and Reprints

ABSTRACT

The principal application of nuclear medicine in metabolic bone disease is the isotope bone scan. Often, it is not a diagnostic tool but can be useful in clarifying the nature of a clinical problem. The best-established role for the bone scan in metabolic bone disease is in Paget's disease, in which it is diagnostic, provides definition of the extent of disease, and probably reflects disease activity. The isotope bone scan is also important in osteoporosis, for which it is not diagnostic but may often provide useful information to confirm that fracture has occurred, determine the age of the fracture, identify unsuspected fractures, and identify other causes for pain, for example, facet joint disease. The bone scan is less useful in other metabolic bone diseases, for example, renal osteodystrophy and osteomalacia, but will often have a characteristic appearance, with several metabolic features. The degree of positivity of the scan generally relates to the severity of the hyperparathyroidism. In patients with metabolic bone disease, other specific clinical problems may arise, such as osteomyelitis or avascular necrosis, and the bone scan may be diagnostic in these conditions. Nuclear medicine techniques are also of value in hyperparathyroidism and to localize the site of the adenoma where surgical treatment is being considered; the use of technetium Tc 99m sestamibi is now routine. More recently, positron emission tomography (PET) scanning has been found to be helpful in the more difficult cases.

KEYWORD

Metabolic bone - bone scan - PET - sestamibi

REFERENCES

  • 1 Fogelman I, Carr D. A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease.  Eur J Nucl Med . 1980;  5 417-421
    PubMedSearch in Google Scholar
  • 2 Ryan P J, Gibson T, Fogelman I. Bone scintigraphy following pamidronate therapy for Paget's disease.  J Nucl Med . 1992;  33 1589-1593
    PubMedSearch in Google Scholar
  • 3 Shirazi P H, Ryan W G, Fordham E W. Bone scanning in evaluation of Paget's disease of the bone.  CRC Crit Rev Clin Radiol Nucl Med . 1974;  5 523-558
    PubMedSearch in Google Scholar
  • 4 Fogelman I, Carr D. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease.  Clin Radiol . 1980;  31 321-326
    CrossrefPubMedSearch in Google Scholar
  • 5 Deutsch A I, Mink J H, Waxman A D. Occult fractures of the proximal femur: MR imaging.  Radiology . 1989;  170 113-116
    PubMedSearch in Google Scholar
  • 6 Ryan P J, Evans P A, Gibson T. Osteoporosis and chronic back pain: a study with single photon emission computed bone scintigraphy.  J Bone Miner Res . 1992;  33 1589-1593
    PubMedSearch in Google Scholar
  • 7 Fogelman I, Citrin D L, Turner J G. Semi-quantitative interpretation of the bone scan in metabolic bone disease.  Eur J Nucl Med . 1979;  4 287-289
    PubMedSearch in Google Scholar
  • 8 Cavalli P L, Camuzzini G F, Ghezzi P. Total body gammography in uraemic patients.  Minerva Nefrol . 1976;  23 142-148
    PubMedSearch in Google Scholar
  • 9 Olgaard K, Heerfordj J, Iasden S. Scinitigraphic skeletal changes in uraemic patients on regular haemodialysis.  Nephron . 1976;  17 325-333
    PubMedSearch in Google Scholar
  • 10 De Graaf P, Schicht I M, Pauwels E KJ, te Velde J, De Graeff J. Bone scintigraphy in renal osteodystrophy.  J Nucl Med . 1978;  19 1289-1296
    PubMedSearch in Google Scholar
  • 11 Fogelman I, MacKillop J H, Greig W R. Pseudofractures of the ribs detected by bone scanning.  J Nucl Med . 1977;  18 1236-1237
    PubMedSearch in Google Scholar
  • 12 Kim K Y, Lee S H, Moon D H. The diagnostic value of triple head single photon emission computed tomography (3H-SPECT) in a vascular necrosis of the femoral head.  Int Orthop . 1993;  17 132-138
    PubMedSearch in Google Scholar
  • 13 Doppman J L, Miller D L. Localisation of parathyroid tumors in patients with asymptomatic hyperparathyroidism and no previous surgery.  J Bone Mineral Res . 1991;  6 S153-S158
    PubMedSearch in Google Scholar
  • 14 Doppman J L, Skarulis M C, Chang R. Hypocalcaemic stimulation and nonselective venous sampling for localizing parathyroid adenomas.  Radiology . 1998;  208 145-151
    PubMedSearch in Google Scholar
  • 15 Johnston B, Carroll M J, Britton K E. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.  J Clin Endocrinol Metab . 1996;  81 346-352
    CrossrefPubMedSearch in Google Scholar
  • 16 Hellman P, Ahlstrom H, Bergstrom M. Positron emission tomography with 11C-methionine in hyperparathyroidism.  Surgery . 1994;  116 974-981
    PubMedSearch in Google Scholar
  • 17 Sundin A, Johansson C, Hellman P. PET and parathyroid L-[carbon-11] methionine accumulation in hyperparathyroidism.  J Nucl Med . 1996;  37 1766-1770
    PubMedSearch in Google Scholar
  • 18 Cook G JR, Wong J CH, Smellie W JB. [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism.  Eur J Endocrinol . 1998;  139 195-197
    CrossrefPubMedSearch in Google Scholar